The U.S. Food and Drug Administration on Thursday announced it has authorized the use of the Healgen Rapid Check COVID-19/Flu ...
By using the dual screening approach, drug developers can identify new targets ... and the race to the market needs a rapid turnaround of data. Capacity can be a challenge, even for companies ...
According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...
Extensively drug-resistant (XDR-TB ... statement in 2008 for the use of molecular line-probe assays for the rapid screening of patients at risk of MDR-TB. This was extended to 27 countries ...